Nevada Cancer Research Foundation
CANCER CONTROL PROTOCOLS
Updated 07/01/2009
 | BRAIN |
| BREAST |
| CANCER PAIN |
| FATIGUE |
| GASTROINTESTINAL |
| GERIATRIC |
| LUNG |
| NAUSEA & VOMITING FROM CHEMOTHERAPY |
| PROSTATE |
| SHORTNESS OF BREATH |
| 0614 - A
RANDOMIZED, PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF MEMANTINE
FOR PREVENTION OF COGNITIVE DYSFUNCTION IN PATIENTS RECEIVING WHOLE-BRAIN
RADIOTHERAPY |
|
V0407
- STATINS
AND BREAST CANCER BIOMARKERS.
Evaluation
of Breast Density and Serum Biomarkers in Response to Statin Administration |
| 40401 - Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer |
| 369901 - OBSERVATIONAL COHORT STUDY: CHEMOTHERAPY DECISIONS AND OUTCOMES IN WOMEN AGE 65 OR OLDER WITH OPERABLE, NEWLY DIAGNOSED BREAST CANCER |
| U07004 - Assesment of Topical Treatment Response with Amitriptyline and Ketamine: Combination Trial in CHemotherapy Peripheral Neuropathy |
|
|
|
79803
-
PHASE
III CHEMOPREVENTION TRIAL OF SELENIUM SUPPLEMENTATION IN PERSONS WITH
RESECTED STAGE I NON-SMALL CELL LUNG CANCER |
| U1105 - PREVENTION OF DELAYED NAUSEA: A PHASE III DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL |
|
|
| U1701 - DYSPNEA IN CANCER PATIENTS |